Literature DB >> 31668904

Polymeric Carriers for Controlled Drug Delivery in Obesity Treatment.

Di Huang1, Meng Deng2, Shihuan Kuang3.   

Abstract

The global rise in the prevalence of obesity and affiliated metabolic syndrome poses a significant threat to human health. Various approaches, including bariatric surgery and pharmacotherapy, have been used in the clinical setting for obesity treatment; however, these conventional options remain ineffective and carry risks of adverse effects. Therefore, treatments with higher efficacy and specificity are urgently required. Emerging drug delivery systems use polymeric materials and chemical strategies to improve therapeutic efficacy and specificity through stabilization and spatiotemporally controlled release of antiobesity agents. In this review, we provide insights into current treatments for obesity with a focus on recent developments of polymeric carriers for enhanced antiobesity drug delivery.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adipose; clinical translation; drug delivery; obesity; pharmacotherapy; polymeric carriers

Mesh:

Substances:

Year:  2019        PMID: 31668904      PMCID: PMC6927547          DOI: 10.1016/j.tem.2019.09.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  85 in total

Review 1.  Inflammatory mechanisms linking obesity and metabolic disease.

Authors:  Alan R Saltiel; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Authors:  W Philip T James; Ian D Caterson; Walmir Coutinho; Nick Finer; Luc F Van Gaal; Aldo P Maggioni; Christian Torp-Pedersen; Arya M Sharma; Gillian M Shepherd; Richard A Rode; Cheryl L Renz
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

3.  Severe obesity and comorbid condition impact on the weight-related quality of life of the adolescent patient.

Authors:  Meg H Zeller; Thomas H Inge; Avani C Modi; Todd M Jenkins; Marc P Michalsky; Michael Helmrath; Anita Courcoulas; Carroll M Harmon; Dana Rofey; Amy Baughcum; Heather Austin; Karin Price; Stavra A Xanthakos; Mary L Brandt; Mary Horlick; Ralph Buncher
Journal:  J Pediatr       Date:  2014-12-30       Impact factor: 4.406

Review 4.  Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.

Authors:  Mark R Prausnitz
Journal:  Annu Rev Chem Biomol Eng       Date:  2017-03-24       Impact factor: 11.059

5.  Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL/6J mice.

Authors:  Manita Dangol; Suyong Kim; Cheng Guo Li; Shayan Fakhraei Lahiji; Mingyu Jang; Yonghao Ma; Inyoung Huh; Hyungil Jung
Journal:  J Control Release       Date:  2017-04-04       Impact factor: 9.776

Review 6.  Notch signaling as a novel regulator of metabolism.

Authors:  Pengpeng Bi; Shihuan Kuang
Journal:  Trends Endocrinol Metab       Date:  2015-03-21       Impact factor: 12.015

7.  Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.

Authors:  Md Nazir Hossen; Kazuaki Kajimoto; Hidetaka Akita; Mamoru Hyodo; Hideyoshi Harashima
Journal:  J Control Release       Date:  2012-09-08       Impact factor: 9.776

8.  Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.

Authors:  R T Long; W S Zeng; L Y Chen; J Guo; Y Z Lin; Q S Huang; S Q Luo
Journal:  Int J Obes (Lond)       Date:  2010-01-12       Impact factor: 5.095

9.  Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.

Authors:  Xiang Yi; Dongfen Yuan; Susan A Farr; William A Banks; Chi-Duen Poon; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-02       Impact factor: 9.776

Review 10.  Anti-obesity drugs: past, present and future.

Authors:  R John Rodgers; Matthias H Tschöp; John P H Wilding
Journal:  Dis Model Mech       Date:  2012-09       Impact factor: 5.758

View more
  5 in total

1.  In Vitro Evaluation of Clinical Candidates of γ-Secretase Inhibitors: Effects on Notch Inhibition and Promoting Beige Adipogenesis and Mitochondrial Biogenesis.

Authors:  Di Huang; Jiamin Qiu; Shihuan Kuang; Meng Deng
Journal:  Pharm Res       Date:  2020-09-04       Impact factor: 4.200

2.  Effectiveness and safety of massage in the treatment of obesity: A protocol for systematic review and meta-analysis.

Authors:  Mengke Jin; Lin Jiao; Jun Li; Daocheng Zhu; Wei Xu; Genping Zhong; Zhiwen Cao; Xuefang Liu
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

3.  Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest.

Authors:  Rong-Fang Mu; Yan-Fen Niu; Qian Wang; Hui-Min Zhou; Jing Hu; Wan-Ying Qin; Wen-Yong Xiong
Journal:  Nat Prod Bioprospect       Date:  2020-04-20

Review 4.  Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Authors:  Jing Li; Hongli Duan; Yan Liu; Lu Wang; Xing Zhou
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

5.  Nanoparticle-Mediated Inhibition of Notch Signaling Promotes Mitochondrial Biogenesis and Reduces Subcutaneous Adipose Tissue Expansion in Pigs.

Authors:  Di Huang; Naagarajan Narayanan; Mario A Cano-Vega; Zhihao Jia; Kolapo M Ajuwon; Shihuan Kuang; Meng Deng
Journal:  iScience       Date:  2020-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.